Literature DB >> 11884273

Angiotensin II-mediated signal transduction pathways.

Yuji Saito1, Bradford C Berk.   

Abstract

The renin-angiotensin system is one of the major cardiovascular systems that controls blood volume, peripheral vascular tone, and blood pressure. Recent studies indicate important roles for angiotensin II in inflammation, atherosclerosis, and congestive heart failure as well. It is gradually becoming clear that angiotensin II exerts effects on the cardiovascular system through several unique mechanisms, including the availability of two different angiotensin II receptors, recruitment of protein tyrosine kinase activity, and receptor tyrosine kinase transactivation. This review discusses the diverse mechanisms of angiotensin II-mediated signal transduction pathways and the various effects of angiotensin II on the cardiovascular system.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11884273     DOI： 10.1007/s11906-002-0042-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  66 in total

1.  Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.

Authors:  J Abe; J Deguchi; T Matsumoto; N Takuwa; M Noda; M Ohno; M Makuuchi; K Kurokawa; Y Takuwa
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

Review 2.  The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

Authors:  D E Dostal; K M Baker
Journal:  Circ Res       Date:  1999-10-01       Impact factor: 17.367

3.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.

Authors:  M B Marrero; B Schieffer; W G Paxton; L Heerdt; B C Berk; P Delafontaine; K E Bernstein
Journal:  Nature       Date:  1995-05-18       Impact factor: 49.962

4.  Nitric oxide inhibits angiotensin II-induced activation of the calcium-sensitive tyrosine kinase proline-rich tyrosine kinase 2 without affecting epidermal growth factor receptor transactivation.

Authors:  D Wang; X Yu; P Brecher
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

Review 5.  Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.

Authors:  Y Saito; B C Berk
Journal:  J Mol Cell Cardiol       Date:  2001-01       Impact factor: 5.000

6.  Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells.

Authors:  U F Mondorf; H Geiger; M Herrero; S Zeuzem; A Piiper
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

7.  Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.

Authors:  S Eguchi; P J Dempsey; G D Frank; E D Motley; T Inagami
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

8.  Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice.

Authors:  M Akishita; M Iwai; L Wu; L Zhang; Y Ouchi; V J Dzau; M Horiuchi
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

9.  Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  G W Booz; K M Baker
Journal:  Hypertension       Date:  1996-10       Impact factor: 10.190

Review 10.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.

Authors:  H Matsubara
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367
View more
  11 in total

Review 1.  Experimental validation of miRNA targets.

Authors:  Donald E Kuhn; Mickey M Martin; David S Feldman; Alvin V Terry; Gerard J Nuovo; Terry S Elton
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

2.  Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure.

Authors:  Raul R Blanco; Harland Austin; Richard N Vest; Ravinder Valadri; Wei Li; Bernard Lassegue; Qing Song; Barry London; Samuel C Dudley; Heather L Bloom; Charles D Searles; A Maziar Zafari
Journal:  J Card Fail       Date:  2012-08-09       Impact factor: 5.712

3.  Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.

Authors:  Zhenghang Zhao; Nadezhda Fefelova; Mayilvahanan Shanmugam; Peter Bishara; Gopal J Babu; Lai-Hua Xie
Journal:  J Mol Cell Cardiol       Date:  2010-11-06       Impact factor: 5.000

Review 4.  The renin-angiotensin system and atherosclerosis.

Authors:  Lucia Mazzolai; Daniel Hayoz
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

5.  Oxidative stress-mediated effects of angiotensin II in the cardiovascular system.

Authors:  Hairuo Wen; Judith K Gwathmey; Lai-Hua Xie
Journal:  World J Hypertens       Date:  2012-08-23

6.  Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB.

Authors:  José L Miguel-Carrasco; Sonia Zambrano; Antonio J Blanca; Alfonso Mate; Carmen M Vázquez
Journal:  J Inflamm (Lond)       Date:  2010-05-12       Impact factor: 4.981

7.  The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.

Authors:  Mickey M Martin; Jessica A Buckenberger; Jinmai Jiang; Geraldine E Malana; Gerard J Nuovo; Maqsood Chotani; David S Feldman; Thomas D Schmittgen; Terry S Elton
Journal:  J Biol Chem       Date:  2007-06-22       Impact factor: 5.157

8.  Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.

Authors:  Jacqueline R Kemp; Hamiyet Unal; Russell Desnoyer; Hong Yue; Anushree Bhatnagar; Sadashiva S Karnik
Journal:  J Mol Cell Cardiol       Date:  2014-06-27       Impact factor: 5.000

9.  TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.

Authors:  Mickey M Martin; Jessica A Buckenberger; Jinmai Jiang; Geraldine E Malana; Daren L Knoell; David S Feldman; Terry S Elton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-06-29       Impact factor: 5.464

Review 10.  Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Leanne Groban
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.